{"data":[{"accessionNo":"0001950047-26-009840","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"PAUL FRIEDMAN","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":50000,"aggregateMarketValue":25828000,"unitsOutstanding":23104126,"approxSaleDate":"2026-09-28","exchange":"NASDAQ","filedAt":"2026-09-28","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-009360","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"WILLIAM SIBOLD","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5221,"aggregateMarketValue":2783419.52,"unitsOutstanding":23104126,"approxSaleDate":"2026-09-11","exchange":"NASDAQ","filedAt":"2026-09-11","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-005407","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"DAVID SOERGEL","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1042,"aggregateMarketValue":518155.34,"unitsOutstanding":23055659,"approxSaleDate":"2026-06-01","exchange":"NASDAQ","filedAt":"2026-06-01","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-004992","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"RICHARD LEVY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5682,"aggregateMarketValue":2918218.38,"unitsOutstanding":23055659,"approxSaleDate":"2026-05-22","exchange":"NASDAQ","filedAt":"2026-05-22","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-015767","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"William Sibold","relationship":"Officer and Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1663,"aggregateMarketValue":730622.42,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"Nasdaq Stock Market","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-015734","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Rebecca Taub","relationship":"Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":491,"aggregateMarketValue":215715.94,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"Nasdaq Stock Market","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-015760","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Shannon Kelley","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":360,"aggregateMarketValue":158162.4,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"Nasdaq Stock Market","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-015740","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Carole Huntsman","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":419,"aggregateMarketValue":184083.46,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"Nasdaq Stock Market","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-002326","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"MARDI DIER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1336,"aggregateMarketValue":586958.24,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"NASDAQ","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-015771","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Mardi Dier","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":646,"aggregateMarketValue":283813.64,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-06","exchange":"Nasdaq Stock Market","filedAt":"2026-03-06","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-013391","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Mardi Dier","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1183,"aggregateMarketValue":511056,"unitsOutstanding":22939969,"approxSaleDate":"2026-03-02","exchange":"Nasdaq Stock Market","filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-003462","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"William Sibold","relationship":"Officer and Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":1577,"aggregateMarketValue":757669.65,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-26","exchange":"Nasdaq Stock Market","filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-003442","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Rebecca Taub","relationship":"Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":647,"aggregateMarketValue":310851.15,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-26","exchange":"Nasdaq Stock Market","filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-000688","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"CAROLE A HUNTSMAN","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":570,"aggregateMarketValue":273856.5,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-26","exchange":"NASDAQ","filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-003478","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Carole Huntsman","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":340,"aggregateMarketValue":163353,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-26","exchange":"Nasdaq Stock Market","filedAt":"2026-01-26","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-002729","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"Rebecca Taub","relationship":"Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2238,"aggregateMarketValue":1122759.84,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-20","exchange":"Nasdaq Stock Market","filedAt":"2026-01-20","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-000588","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"SHANNON KELLEY","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":429,"aggregateMarketValue":215220.72,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-20","exchange":"NASDAQ","filedAt":"2026-01-20","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-26-002739","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"Shannon Kelley","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":263,"aggregateMarketValue":131941.84,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-20","exchange":"Nasdaq Stock Market","filedAt":"2026-01-20","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-26-000299","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"REBECCA A TAUB","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":18650,"aggregateMarketValue":10373503,"unitsOutstanding":22711420,"approxSaleDate":"2026-01-09","exchange":"NASDAQ","filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-25-010079","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"REBECCA A TAUB","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":18650,"aggregateMarketValue":10330608,"unitsOutstanding":22711420,"approxSaleDate":"2025-12-10","exchange":"NASDAQ","filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-25-010080","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"PAUL FRIEDMAN","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":49600,"aggregateMarketValue":27474432,"unitsOutstanding":22711420,"approxSaleDate":"2025-12-10","exchange":"NASDAQ","filedAt":"2025-12-10","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-25-055416","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"William John Sibold","relationship":"Officer and Director","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2400,"aggregateMarketValue":1391736,"unitsOutstanding":22711420,"approxSaleDate":"2025-12-04","exchange":"Nasdaq Stock Market","filedAt":"2025-12-04","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-25-009623","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"MARDI C DIER","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4173,"aggregateMarketValue":2418044.85,"unitsOutstanding":22711420,"approxSaleDate":"2025-12-02","exchange":"NASDAQ","filedAt":"2025-12-02","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001628280-25-053607","issuerCik":"0001157601","issuerName":"Madrigal Pharmaceuticals, Inc.","ticker":"MDGL","personName":"Carole Huntsman","relationship":"Officer","securityClass":"Common Stock","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":894,"aggregateMarketValue":484655.28,"unitsOutstanding":22711420,"approxSaleDate":"2025-11-21","exchange":"Nasdaq Stock Market","filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-25-008831","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS INC","ticker":"MDGL","personName":"RICHARD S LEVY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":8500,"aggregateMarketValue":4495990,"unitsOutstanding":22711420,"approxSaleDate":"2025-11-13","exchange":"NASDAQ","filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"},{"accessionNo":"0001950047-25-008473","issuerCik":"0001157601","issuerName":"MADRIGAL PHARMACEUTICALS, INC.","ticker":"MDGL","personName":"KENNETH M BATE","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16575,"aggregateMarketValue":8027353.72,"unitsOutstanding":22711420,"approxSaleDate":"2025-11-05","exchange":"NASDAQ","filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl"}],"updatedAt":"2026-10-29T13:47:55.057Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mdgl","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}